뒤로
Proteomics International Laboratories Ltd(PIQLF) 가격
PIQLF 주가 차트
PIQLF 수입
Proteomics International Laboratories Ltd
$0.26
0%
$0
종가: Jan 22, 16:00:00 GMT-5
$0.26
0%
$0
애프터마켓: Jan 22, 20:00:00 GMT-5
Earnings FAQ
PIQLF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Proteomics International Laboratories Ltd PIQLF의 지난 분기 매출 실적은 어땠나요?
Proteomics International Laboratories Ltd의 매출 추정치는 얼마인가요?
Proteomics International Laboratories Ltd의 수익 품질 점수는 얼마인가요?
Proteomics International Laboratories Ltd는 언제 수익을 보고하나요?
Proteomics International Laboratories Ltd의 예상 수익은 얼마인가요?
Proteomics International Laboratories Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.26
시가
--
일일 범위
-
52주 범위
$0.26 - $0.31
거래량
--
평균 거래량
16
EPS(TTM)
-0.04
배당수익률
--
시가총액
$42.5M
PIQLF란 무엇인가요?
Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bioanalytical services. The company specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. The company focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identifying up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.